American journal of therapeutics最新文献

筛选
英文 中文
A Study on Periorbital Edema Following Postcollagen Injection. 关于注射胶原蛋白后眶周水肿的研究
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-06 DOI: 10.1097/MJT.0000000000001793
Huinan Chang, Leilei Guo
{"title":"A Study on Periorbital Edema Following Postcollagen Injection.","authors":"Huinan Chang, Leilei Guo","doi":"10.1097/MJT.0000000000001793","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001793","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Insights Into Pharmacology of GABAA Receptor Alpha Subunits-Selective Modulators. GABAA 受体α亚基-选择性调节剂药理学的新见解。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-06 DOI: 10.1097/MJT.0000000000001810
Miruna Valeria Moraru, Smaranda Stoleru, Aurelian Zugravu, Oana Andreia Coman, Ion Fulga
{"title":"New Insights Into Pharmacology of GABAA Receptor Alpha Subunits-Selective Modulators.","authors":"Miruna Valeria Moraru, Smaranda Stoleru, Aurelian Zugravu, Oana Andreia Coman, Ion Fulga","doi":"10.1097/MJT.0000000000001810","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001810","url":null,"abstract":"<p><strong>Background: </strong>Benzodiazepines have long held a leading position in medical therapeutics, known for their multiple common therapeutic properties and primarily being prescribed for anxiety and insomnia. However, their lack of specificity and various side effects have led to a reevaluation of their long-term use, resulting in a rapid growth in the literature focusing on targeted therapies.</p><p><strong>Areas of uncertainty: </strong>Despite many efforts, uncertainties persist and there are heterogeneous findings across studies regarding the pharmacological effects attributed to gamma-aminobutyric acid type A (GABAA) receptor subunits. Selective compounds targeting GABAA receptor alpha subunits are currently under active research and definitive conclusions have not been reached yet. Some compounds have not progressed to clinical trials, while others, if advanced, have been halted. These challenges emphasize the difficulty in translating preclinical findings into clinical use.</p><p><strong>Data sources: </strong>A literature review was conducted using the PubMed database, searching for articles discussing GABAA receptor subunits. The search was refined by including only selective compounds with potential anxiolytic and cognitive enhancement properties.</p><p><strong>Results: </strong>Findings reveal compounds with promising anxiolytic and antidepressant effects with minimal sedation and absence of tolerance development. Moreover, some compounds show potential in alleviating cognitive dysfunction. There is a broad spectrum of potential therapeutic applications for selective compounds, ranging from neurological disorders such as epilepsy and neuropathic pain to cognitive dysfunction-related conditions. Currently, the leading selective compounds with the most promising results in ongoing clinical trials are basmisanil and darigabat. Basmisanil holds further exploration potential in the treatment of cognitive impairment and related conditions, while darigabat shows progress in the advancement of adjunctive therapy of focal onset seizures and for the treatment of panic disorder, respectively.</p><p><strong>Conclusions: </strong>Future drug discovery efforts are encouraged to focus on positive allosteric modulators that selectively target the α2, α3 subunits and negative/positive allosteric modulators that target the α5 subunit of the GABAA receptor. The pursuit of ligands possessing only anxiolytic effects or those enhancing cognition continues to be an important focus for future research, with promising advancements depicted in recent studies.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Nocebo Effect: A Bias in Clinical Practice-An Ethical Approach. 恐慌效应:临床实践中的偏见--一种伦理方法。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 Epub Date: 2024-04-02 DOI: 10.1097/MJT.0000000000001730
Iulia-Virginia Răducan-Florea, Florin G Leaşu, Eleonora A Dinu, Liliana M Rogozea
{"title":"The Nocebo Effect: A Bias in Clinical Practice-An Ethical Approach.","authors":"Iulia-Virginia Răducan-Florea, Florin G Leaşu, Eleonora A Dinu, Liliana M Rogozea","doi":"10.1097/MJT.0000000000001730","DOIUrl":"10.1097/MJT.0000000000001730","url":null,"abstract":"<p><strong>Background: </strong>The nocebo effect is often disregarded in medical practice and is certainly much less known than the placebo effect, although, in reality, both can influence therapeutic decision making and the quality of life of patients. However, the nocebo effect raises a number of issues not only of a practical nature related to clinical activity but also ethical dilemmas related to the observance of the patient's autonomy, nonmaleficence, or informed consent and the information on which it is based.</p><p><strong>Areas of uncertainty: </strong>The ethical dilemmas raised by the nocebo effect revolve around how informed consent can be achieved, the accuracy and volume of information that is transmitted to the patient, and how to report negative side effects of therapeutic treatment.</p><p><strong>Data sources: </strong>In September 2023, a narrative analysis of the literature was conducted using a combination of keywords such as nocebo, placebo, ethics, therapeutic relationship from PubMed, Scopus, Google Scholar, and so on, as well as from official documents developed at an international level (World Health Organization), for a period of 10 years (2012-2021).</p><p><strong>Results: </strong>Analyzing the articles that remarked upon the significant impact of ethics in nocebo research or in the therapeutic relationship, we can state that the existence of several relevant issues of interest have been detected regarding the ethical use of nocebo and its impact in research or in clinics and thus the need for proper knowledge and management of the impact of nocebo effects. The ethical paradox of obtaining informed consent with the 2 goals, first, the need for complete information and second, the preservation of the autonomy of the patient, respectively, that of \"primum non-nocere\" and of avoiding unnecessary harm by revealing probable adverse effects is a point of interest for numerous studies. The potential for a nocebo effect is present when we inform patients about the risks and benefits of treatment, there being a clear link between the moral and ethical duty to inform patients and the need to avoid situations that increase the nocebo impact on how the disease or the adverse effects of the treatment are perceived. Adapting information about the side effects of medicines should focus on ensuring a balance between transparency and caution, especially in patients with a high potential for nocebo effect.</p><p><strong>Conclusions: </strong>The nocebo effect had for a long time been unknown or denied, although it can interfere with the results of the treatment used. As the nocebo phenomenon becomes increasingly known in medical practice, the clinical and ethical implications are identified by medical staff, and nocebo's adverse responses are no longer ignored.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e541-e549"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test. 波他巴诱发 DRESS 综合征的一个罕见病例,斑贴试验呈阳性。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001745
Yasmine Salem Mahjoubi, Imen Hamza, Ghozlane Lakhoua, Ons Charfi, Ahmed Zaiem, Sarah Kastalli, Sihem El Aidli
{"title":"An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test.","authors":"Yasmine Salem Mahjoubi, Imen Hamza, Ghozlane Lakhoua, Ons Charfi, Ahmed Zaiem, Sarah Kastalli, Sihem El Aidli","doi":"10.1097/MJT.0000000000001745","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001745","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e600-e602"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Infusion of Turoctocog Alfa in Patients With Mild to Moderate Hemophilia A: A Case Series. 连续输注 Turoctocog Alfa 治疗轻度至中度血友病 A 患者:一个病例系列。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 Epub Date: 2024-07-11 DOI: 10.1097/MJT.0000000000001713
Megan Wayman, Loan Nguyen, Donald C Moore, Mary Ann Knovich, Justin Arnall
{"title":"Continuous Infusion of Turoctocog Alfa in Patients With Mild to Moderate Hemophilia A: A Case Series.","authors":"Megan Wayman, Loan Nguyen, Donald C Moore, Mary Ann Knovich, Justin Arnall","doi":"10.1097/MJT.0000000000001713","DOIUrl":"10.1097/MJT.0000000000001713","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e564-e566"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141578723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled Anesthetic Sevoflurane-Associated Diffuse Alveolar Hemorrhage. 吸入麻醉剂七氟醚引发的弥漫性肺泡出血。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001737
Tahrima Ferdous, Zachary Holtzapple, Amna Al-Tkrit, Ragheb Assaly
{"title":"Inhaled Anesthetic Sevoflurane-Associated Diffuse Alveolar Hemorrhage.","authors":"Tahrima Ferdous, Zachary Holtzapple, Amna Al-Tkrit, Ragheb Assaly","doi":"10.1097/MJT.0000000000001737","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001737","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e591-e593"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ixabepilone-Induced Delirium. 伊沙匹隆诱发的谵妄。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001677
Tzu-Ching Yang, Yi-Wei Yeh, Fang-Jung Wan, Tzu-Chuan Huang, Shiue-Wei Lai, Nian-Sheng Tzeng
{"title":"Ixabepilone-Induced Delirium.","authors":"Tzu-Ching Yang, Yi-Wei Yeh, Fang-Jung Wan, Tzu-Chuan Huang, Shiue-Wei Lai, Nian-Sheng Tzeng","doi":"10.1097/MJT.0000000000001677","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001677","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e556-e557"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nivolumab-Associated Concurrent Central Diabetes Insipidus and Acute Interstitial Nephritis. Nivolumab并发中枢性糖尿病和急性间质性肾炎。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001757
Tanju Kapagan, Kubra Ugur, Mehmet Turkmencalikoglu, Nilufer Bulut, Gokmen Umut Erdem
{"title":"Nivolumab-Associated Concurrent Central Diabetes Insipidus and Acute Interstitial Nephritis.","authors":"Tanju Kapagan, Kubra Ugur, Mehmet Turkmencalikoglu, Nilufer Bulut, Gokmen Umut Erdem","doi":"10.1097/MJT.0000000000001757","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001757","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e622-e626"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TEN Associated With Perampanel Administration in An Old Man to Prevent Epilepsy After Removal of Cerebellar Hematoma. 一名老人在切除小脑血肿后为预防癫痫而服用培南帕尼时引发的 TEN。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001697
Yinhua Gong, Jinfang Shi, Ming Liu, Cheng Xie, Jie Gao
{"title":"TEN Associated With Perampanel Administration in An Old Man to Prevent Epilepsy After Removal of Cerebellar Hematoma.","authors":"Yinhua Gong, Jinfang Shi, Ming Liu, Cheng Xie, Jie Gao","doi":"10.1097/MJT.0000000000001697","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001697","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e557-e560"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Dosage of Apatinib as Salvage Treatment in Metastatic Lung Cancer With Clear Cell Renal Cell Carcinoma. 低剂量阿帕替尼作为转移性肺癌合并透明细胞肾细胞癌的挽救治疗方案
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001731
Su-Yun Ding, Wei-Yun Zhang, Meng-Lan Zhang, Da-Xiong Zeng
{"title":"Low Dosage of Apatinib as Salvage Treatment in Metastatic Lung Cancer With Clear Cell Renal Cell Carcinoma.","authors":"Su-Yun Ding, Wei-Yun Zhang, Meng-Lan Zhang, Da-Xiong Zeng","doi":"10.1097/MJT.0000000000001731","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001731","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e578-e580"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信